| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/30/2007 | US7169401 Topical skin care composition containing refined peanut oil |
| 01/30/2007 | US7169391 Oil in water emulsions; induction immunology response; antigens |
| 01/30/2007 | US7169383 Attaching substances to micro-organisms |
| 01/30/2007 | US7169382 Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds |
| 01/30/2007 | US7169381 Aqueous solution of polyoxyethylene glycol , ascorbic acid and electrolyte |
| 01/30/2007 | US7169379 Cosmetics |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | US7169318 Imbibed organic liquids, especially halogenated organics |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2411153C Method for preparing a composition |
| 01/30/2007 | CA2252609C Polyol composition |
| 01/30/2007 | CA2251002C Estradiol and progesterone-based medicament |
| 01/25/2007 | WO2007012013A2 Polymer conjugates to therapeutic agents via an si-n and/or an si-o linkage |
| 01/25/2007 | WO2007011985A1 Compositions for the reversible thioesterification of signaling proteins and methods of using same |
| 01/25/2007 | WO2007011892A2 Stimulant-containing nutrition bar product and method of manufacture |
| 01/25/2007 | WO2007011764A2 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 01/25/2007 | WO2007011217A2 Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes |
| 01/25/2007 | WO2007011166A1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 01/25/2007 | WO2007011018A1 Rapidly disintegratable oral tablet |
| 01/25/2007 | WO2007010930A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
| 01/25/2007 | WO2007010847A1 Sustained release preparation |
| 01/25/2007 | WO2007010846A1 Preparation having gastric residence capability |
| 01/25/2007 | WO2007010552A2 N- terminal peg conjugate of erythropoietin |
| 01/25/2007 | WO2007010430A2 Pharmaceutical composition for treating xerostomia |
| 01/25/2007 | WO2007010231A1 Modified antibody fragments |
| 01/25/2007 | WO2007010032A2 Intermolecular association complex of a carrier, preferably an n-alkylamino -1-desoxylactitol and of an active ingredient |
| 01/25/2007 | WO2007010023A1 Medicated gauze |
| 01/25/2007 | WO2007009894A2 Peptides for use in the treatment of obesity |
| 01/25/2007 | WO2007009320A1 A preparation of statins for prolonged release |
| 01/25/2007 | WO2007009265A1 NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS |
| 01/25/2007 | WO2007009229A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 01/25/2007 | WO2007009208A1 Poly(ethylene glocol) modified human gm-csf with increased biological activity |
| 01/25/2007 | WO2006128266A3 Pharmaceutical compositions of the peptide angiotensin-(1 -7) [ang-(i -7)] and its analogues, agonists and antagonists, for use in controlling the functions of the reproductive system |
| 01/25/2007 | WO2006117516A3 Topical compositions |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006102345A3 Methods and systems for operating an aerosol generator |
| 01/25/2007 | WO2006097537A3 Acylated glp-1 compounds |
| 01/25/2007 | WO2006085143A3 Improved bioactive agent compositions for repair of cell injuries |
| 01/25/2007 | WO2006068899A3 Preserved ophthalmic compositions comprising aloe vera |
| 01/25/2007 | WO2006053761A3 Modified plant gums for preparations of active ingredients |
| 01/25/2007 | WO2006036568A3 Antibody buffering of a ligand in vivo |
| 01/25/2007 | WO2006027116A3 P277 peptide formulations or variants thereof having optimised stability |
| 01/25/2007 | WO2006010057A3 Therapeutic peptides |
| 01/25/2007 | US20070021438 Itraconazole solution |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070021344 Stabilized teriparatide solutions |
| 01/25/2007 | US20070021343 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis |
| 01/25/2007 | US20070021338 Stabilised compositions of Factor VII |
| 01/25/2007 | US20070021327 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor |
| 01/25/2007 | US20070020761 Solid surface for biomolecule delivery and high-throughput assay |
| 01/25/2007 | US20070020734 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020694 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 01/25/2007 | US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2007 | US20070020337 Paclitaxel-based antitumor formulation |
| 01/25/2007 | US20070020313 Composition of amylase inhibitors and fibers to reduce the absorption of starch in human digestion from starchy foods, and to reduce the glycemic index of starchy foods |
| 01/25/2007 | US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/25/2007 | US20070020294 Use of botulinum toxin for treatment of articular pathologies |
| 01/25/2007 | US20070020289 Preparations and processes for stabilizing biological materials by means of drying processes without freezing |
| 01/25/2007 | US20070020282 Monoglycerides; fatty acids; for parenteral or mucosal administration of antigens and/or vaccines to humans and animals |
| 01/25/2007 | US20070020272 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020264 Serum albumin binding peptides for tumor targeting |
| 01/25/2007 | US20070020255 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 01/25/2007 | US20070020252 Modified protease inhibitors |
| 01/25/2007 | US20070020241 Use of photosensitisation |
| 01/25/2007 | US20070020235 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020226 Polyacrylamide Hydrogel For The Treatment of Incontinence and Vesicouretal Reflux |
| 01/25/2007 | US20070020224 Protein-proteophore complexes |
| 01/25/2007 | US20070020192 Delivery of therapeutics conjugated to neonatal Fc receptor (FcRn) binding partner to intestinal, mucosal epithelium and epithelium of the lung; elicit immune response; systemic delivery of an interferon across an epithelial barrier |
| 01/25/2007 | CA2838108A1 Sustained release of antiinfectives |
| 01/25/2007 | CA2658491A1 Membrane-translocating peptides |
| 01/25/2007 | CA2616583A1 Peptides for use in the treatment of obesity |
| 01/25/2007 | CA2616116A1 Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes |
| 01/25/2007 | CA2616092A1 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 01/25/2007 | CA2616091A1 Intermolecular association complex of a carrier and of an active principle |
| 01/25/2007 | CA2616012A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
| 01/25/2007 | CA2615861A1 Polymer conjugates to therapeutic agents via an si-n and/or an si-o linkage |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615485A1 Modified antibody fragments |
| 01/25/2007 | CA2615360A1 Formulation and method for administration of ophthalmologically active agents |
| 01/25/2007 | CA2615231A1 Prevention and treatment of ophthalmic complications of diabetes |
| 01/25/2007 | CA2614987A1 Method for preparing polymer maleimides |
| 01/25/2007 | CA2614764A1 Sustained release of antiinfectives |
| 01/25/2007 | CA2614687A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 01/25/2007 | CA2614187A1 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 01/25/2007 | CA2613178A1 Sustained release preparation |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1745802A1 Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes |
| 01/24/2007 | EP1745774A2 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/24/2007 | EP1745078A1 Method for the purification of albumin conjugates |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1744787A1 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 01/24/2007 | EP1744786A2 Chemically modified protein compositions and methods |
| 01/24/2007 | EP1744785A1 Hydroxyalkyl derivatives of biologically active compounds |
| 01/24/2007 | EP1744784A2 Formulations of anti-pain agents and methods of using the same |
| 01/24/2007 | EP1744783A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 01/24/2007 | EP1744782A1 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |